Titrating clozapine amidst recommendations proposing high myocarditis risk and rapid titrations (original) (raw)

Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study

Duncan J Topliss

Schizophrenia research, 2012

View PDFchevron_right

New Monitoring Guidelines for Clozapine-Induced Myocarditis Based on an Analysis of 75 Cases and 94 Controls

Duncan J Topliss

Heart, Lung and Circulation, 2010

View PDFchevron_right

Clozapine-Associated Myocarditis

Andrew Tonkin

Drug Safety, 2007

View PDFchevron_right

Clozapine-induced myocarditis in observational cross-sectional and follow-up evaluations: comparison with other antipsychotics in naturalistic settings

Trino Baptista

2016

View PDFchevron_right

A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls

Duncan J Topliss

Australian and New Zealand Journal of Psychiatry, 2011

View PDFchevron_right

An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine

Trino Baptista

General Psychiatry

View PDFchevron_right

Myocarditis and cardiomyopathy associated with clozapine

David Celermajer

The Lancet, 1999

View PDFchevron_right

A systematic review of clozapine-induced myocarditis

Malcolm Tingle

International Journal of Cardiology, 2018

View PDFchevron_right

Clozapine Induced Myocarditis: a case report

JAVED ATHER SIDDIQUI

Indian Journal of Mental Health 2023; 10(1), 2024

View PDFchevron_right

Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases

Duncan J Topliss

Schizophrenia Research, 2011

View PDFchevron_right

Clozapine associated cardiotoxicity: Issues, challenges and way forward

Guna Sekaran Kanniah

Asian Journal of Psychiatry, 2020

View PDFchevron_right

Myocarditis after administration of Clozapine

Marina Economou

View PDFchevron_right

Clozapine-induced myocarditis: A rare adverse drug reaction not to ignore

rim sellami

Therapie, 2018

View PDFchevron_right

Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience

Melissa Petrakis

Australasian Psychiatry, 2013

View PDFchevron_right

A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology

Carlos De Las Cuevas

Psychotherapy and Psychosomatics, 2020

View PDFchevron_right

A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns

Stephen Saklad

Clinical schizophrenia & related psychoses, 2016

View PDFchevron_right

A Case of Suspected Clozapine Related Myocarditis

Rusdi Abd Rashid

View PDFchevron_right

Monitoring the Safe Use of Clozapine

Seetal Dodd

CNS Drugs, 2007

View PDFchevron_right

Rechallenge of clozapine in a patient with a history of clozapine-induced myocarditis

melike kucukkarapinar

Dusunen Adam: The Journal of Psychiatry and Neurological Sciences, 2020

View PDFchevron_right

Kidd, S* and Chopra, P* and Stone, J* and Jackson, T* and Gwee, K* and Maynard, S* and Ellis, IK and Judd, F*, ‘Monitoring of long-term cardia complications in patients receiving clozapine’, Australian Psychiatry, 21 (1) pp. 77-78. ISSN 1440-1665 (2012)

Isabelle Ellis

View PDFchevron_right

Diagnostic Characteristics of Clozapine-Induced Myocarditis Identified by an Analysis of 38 Cases and 47 Controls

Duncan J Topliss

The Journal of Clinical Psychiatry, 2010

View PDFchevron_right

Does a subclinical cardiotoxic effect of clozapine exist? Results from a follow-up pilot study

Carlo Rostagno

Cardiovascular & hematological agents in medicinal chemistry, 2012

View PDFchevron_right

Clozapine-induced myocarditis: Two case reports and review of clinical presentation and recognition

Troy Moore

Mental Health Clinician, 2018

View PDFchevron_right

Update on the Adverse Effects of Clozapine: Focus on Myocarditis

Domenico De Berardis

Current Drug Safety, 2012

View PDFchevron_right

Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review

Philippos Gourzis

Pharmaceuticals

View PDFchevron_right

Myocarditis During Clozapine Treatment

jeffrey lieberman

View PDFchevron_right

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

Niko Seppälä

Pharmacopsychiatry, 2022

View PDFchevron_right

Clozapine-Induced Hypersensitivity Myocarditis*

Roberto Cavallaro

CHEST Journal, 2004

View PDFchevron_right

An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s

Carlos De Las Cuevas

European Archives of Psychiatry and Clinical Neuroscience

View PDFchevron_right

Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration

Sujoy Mukherjee

International Clinical Psychopharmacology, 2007

View PDFchevron_right

Resolution without discontinuation: heart failure during clozapine treatment

Emma Khosla

Therapeutic Advances in Psychopharmacology, 2020

View PDFchevron_right

Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review

David Kim

Frontiers in neuroscience, 2018

View PDFchevron_right

Impairment of left ventricular function early in treatment with clozapine: a preliminary study

Carlotta Gasperoni, Martina Curto, Iginia Mancinelli

International clinical psychopharmacology, 2015

View PDFchevron_right

Clozapine: A Clinical Review of Adverse Effects and Management

Masud Iqbal

Annals of Clinical Psychiatry, 2003

View PDFchevron_right